EurekAlert! -
5 May 2020 06:00
(Johannes Gutenberg Universitaet Mainz) Several drugs approved for treating hepatitis C viral infection were identified as potential candidates against COVID-19, a new disease caused by the SARS-CoV-2 coronavirus. This is the result of research based on extensive calculations using the MOGON II supercomputer at Johannes Gutenberg University Mainz (JGU).
Share this Article